Dynamic borrowing via covariate-adjusted self-adapting mixture priors in clinical trials
Related Experiment Video
Updated: Nov 6, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
1Department of Statistics, Sungkyunkwan University, Jongno-gu, Republic of Korea.
Abstract:
Incorporating historical data into clinical trials can enhance statistical power, but it risks introducing bias if historical and current populations differ. Existing Bayesian borrowing methods often apply a single, prespecified weight to historical data, failing to account for patient-level covariate differences. To address this, we propose a covariate-adjusted self-adapting mixture (CASAM) prior, a Bayesian framework that enables covariate-dependent dynamic borrowing from external data. CASAM adaptively determines the degree of information borrowing by assessing the compatibility between historical and current data conditional on covariates, automatically down-weighting historical information when residual heterogeneity is detected. To further address covariate distribution mismatch between historical and current trials, we develop a propensity-score-integrated implementation of CASAM, which first re-weights historical controls to align their covariate distribution with that of the current control arm before applying the CASAM prior. This layered strategy allows CASAM to focus on structural similarity while the propensity-score adjustment corrects for population-level imbalance. Together, CASAM and its propensity-score-based implementation provide an empirical-Bayes framework for adaptive borrowing that combines covariate alignment with outcome-model compatibility assessment.
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.